349 related articles for article (PubMed ID: 30507030)
1. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
[TBL] [Abstract][Full Text] [Related]
2. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
3. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
[TBL] [Abstract][Full Text] [Related]
5. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
7. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
Charatcharoenwitthaya P; Enders FB; Halling KC; Lindor KD
Hepatology; 2008 Oct; 48(4):1106-17. PubMed ID: 18785620
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
9. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
[TBL] [Abstract][Full Text] [Related]
10. Cholangioscopy Biopsies Improve Detection of Cholangiocarcinoma When Combined with Cytology and FISH, but Not in Patients with PSC.
Kaura K; Sawas T; Bazerbachi F; Storm AC; Martin JA; Gores GJ; Abu Dayyeh BK; Topazian MD; Levy MJ; Petersen BT; Chandrasekhara V
Dig Dis Sci; 2020 May; 65(5):1471-1478. PubMed ID: 31571103
[TBL] [Abstract][Full Text] [Related]
11. Role of biliary brush cytology in primary sclerosing cholangitis.
Lal A; Okonkwo A; Schindler S; De Frias D; Nayar R
Acta Cytol; 2004; 48(1):9-12. PubMed ID: 14969174
[TBL] [Abstract][Full Text] [Related]
12. Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis.
Vannas MJ; Boyd S; Färkkilä MA; Arola J; Isoniemi H
Liver Int; 2017 May; 37(5):735-742. PubMed ID: 28453918
[TBL] [Abstract][Full Text] [Related]
13. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
[TBL] [Abstract][Full Text] [Related]
14. Recall processes for biliary cytology in primary sclerosing cholangitis.
Eaton JE; Gossard AA; Talwalkar JA
Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
[TBL] [Abstract][Full Text] [Related]
15. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
[TBL] [Abstract][Full Text] [Related]
16. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.
Trikudanathan G; Navaneethan U; Njei B; Vargo JJ; Parsi MA
Gastrointest Endosc; 2014 May; 79(5):783-9. PubMed ID: 24140129
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
[TBL] [Abstract][Full Text] [Related]
19. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Njei B; McCarty TR; Varadarajulu S; Navaneethan U
Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
[TBL] [Abstract][Full Text] [Related]
20. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]